Erika Abelleira

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Infectious Diseases

Replacement Therapy

Metastatic Colorectal Cancer

Electronic Health Record

Top Venues

Reviews in endocrine & metabolic disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, Fabián Pitoia
Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer. Endocrine (2024)
Fabián Pitoia, Pierpaolo Trimboli, Erika Abelleira
Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancer. Endocrine (2024)
Fernando Jerkovich, Soledad Capalbo, Erika Abelleira, Fabián Pitoia
Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancer. Endocrine 85 (2) (2024)
Fernanda Bueno, Anabella Smulever, Inés Califano, Jorgelina Guerra, Andrés Del Grecco, Juan Manuel Carrera, Raúl Giglio, Manglio Rizzo, Alejo Lingua, Ana Voogd, María Del Carmen Negueruela, Erika Abelleira, Fabián Pitoia
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience. Endocrine (2023)
Erika Abelleira, Fernando Jerkovich
Dynamic risk assessment in patients with differentiated thyroid cancer. Reviews in endocrine & metabolic disorders (2023)
Fernanda Bueno, Anabella Smulever, Inés Califano, Jorgelina Guerra, Andrés Del Grecco, Juan Manuel Carrera, Raúl Giglio, Manglio Rizzo, Alejo Lingua, Ana Voogd, María Del Carmen Negueruela, Erika Abelleira, Fabián Pitoia
Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience. Endocrine (2023)
Anabella Smulever, Erika Abelleira, Fernanda Bueno, Fabián Pitoia
Thyroid cancer in the Era of COVID-19. Endocrine 70 (1) (2020)